NewYork-Presbyterian Hospital/Weill Cornell Medical Center recently announced that they will be the first and only hospital in the five boroughs of New York City to offer women with early stage breast cancer INTRABEAM radiotherapy, an innovative radiation treatment delivered in a single dose at the time of surgery.
Women with early stage breast cancer often have breast-conserving surgery, also called a lumpectomy, to remove a cancerous tumor. Lumpectomy is followed by a regimen of daily doses of radiation therapy to the entire breast, generally lasting six to seven weeks.
NTRABEAM radiotherapy may be an effective alternative to a six to seven week radiation regimen following surgery for select women because it allows precise targeting of any remaining cancer cells right inside the tumor bed where the tumor is most likely to recur.
In a 10-year randomized phase 3 clinical trial of breast cancer intraoperative therapy, a single dose radiation applied at the time of surgery had the same results as the six to seven week full-breast radiation therapy.